XOMA Royalty (XOMA) said Friday it has completed its previously announced acquisition of Mural Oncology (MURA).
The acquisition was approved by Mural shareholders on Oct. 24 and later was sanctioned by the Irish High Court on Dec. 3, XOMA Royalty said.
Mural Oncology shares will be delisted from Nasdaq and deregistered, XOMA Royalty said.
Price: 31.13, Change: +0.13, Percent Change: +0.42
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments